These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17053895)

  • 41. [Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
    Wang SQ; Christophel E; Lin SG; Meng F; Hu XM; Wang GZ; Liu J; Zeng LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):50-2. PubMed ID: 18637586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
    Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
    Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
    Sugiarto SR; Singh B; Page-Sharp M; Davis WA; Salman S; Hii KC; Davis TME
    Br J Clin Pharmacol; 2022 Feb; 88(2):691-701. PubMed ID: 34296469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
    Krudsood S; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Treeprasertsuk S; Kano S; Brittenham GM; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):316-21. PubMed ID: 12971556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of falciparum malaria with artemether-lumefantrine according to a 5-day schedule: results of a study in 21 patients and recommendations].
    Visser LG; Berger P; den HJ; van Wout JW
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2208-13. PubMed ID: 17969572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
    Stohrer JM; Dittrich S; Thongpaseuth V; Vanisaveth V; Phetsouvanh R; Phompida S; Monti F; Christophel EM; Lindegardh N; Annerberg A; Jelinek T
    Trop Med Int Health; 2004 Nov; 9(11):1175-83. PubMed ID: 15548313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
    Vos K; Sciuto CL; Piedade R; Ashton M; Björkman A; Ngasala B; Mårtensson A; Gil JP
    Pharmacogenomics; 2017 Jul; 18(10):981-985. PubMed ID: 28639487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.
    Vugt MV; Wilairatana P; Gemperli B; Gathmann I; Phaipun L; Brockman A; Luxemburger C; White NJ; Nosten F; Looareesuwan S
    Am J Trop Med Hyg; 1999 Jun; 60(6):936-42. PubMed ID: 10403324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE
    Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artemether-lumefantrine for treating uncomplicated falciparum malaria.
    Omari AA; Preston C; Garner P
    Cochrane Database Syst Rev; 2003; (2):CD003125. PubMed ID: 12804451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
    Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
    Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
    PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger.
    Denoeud-Ndam L; Dicko A; Baudin E; Guindo O; Grandesso F; Diawara H; Sissoko S; Sanogo K; Traoré S; Keita S; Barry A; de Smet M; Lasry E; Smit M; Wiesner L; Barnes KI; Djimde AA; Guerin PJ; Grais RF; Doumbo OK; Etard JF
    BMC Med; 2016 Oct; 14(1):167. PubMed ID: 27776521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.
    Minzi OM; Marealle IA; Shekalaghe S; Juma O; Ngaimisi E; Chemba M; Rutaihwa M; Abdulla S; Sasi P
    Malar J; 2013 May; 12():174. PubMed ID: 23718725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.
    Bassat Q; Ogutu B; Djimde A; Stricker K; Hamed K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4366-74. PubMed ID: 26014953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.